Accelerating Precision Medicine by Pairing Next-Generation Sequencing (NGS) Kits with Ready-to-Use Analysis Workflows

Across all industries, people are changing the ways they engage with products, services, and brands. As a result, life sciences companies find themselves challenged to compete for mindshare in an increasingly noisy market. To stay relevant, pharma marketers must re-evaluate their traditional commercial models and address the changing expectations of their customers—at scale. In this free podcast, Aptus Health in association with PharmaTimes, will explore opportunities pharma marketers have to leverage digital communications to create engaging, high-value experiences for their target markets. We’ll also share examples of how the right technologies and approaches drive meaningful outcomes.

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars.

Microbial risk in pharmaceutical process is not limited to living microorganisms and intact microbial cells. Subcellular components from microorganisms remaining from the production process can be source of pyrogens, compromising product quality and patient safety as these substances are not eliminated by classical filtration or sterilization steps.

T3P or propanephosphonic acid anhydride, is an exceptional green reagent for use in condensation reactions and has attracted the attention of almost all innovative pharmaceutical companies worldwide during the past decade.